SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

NRC’s hybrid AI workshop coming up

September 18, 2025, 7:21AMNuclear News

The Nuclear Regulatory Commission will host a hybrid public workshop on September 24 from 9 a.m.-5 p.m. Eastern time to discuss its activities for the safe and secure use of artificial...